TrialExperimental dermatology2026

A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low-Risk Basal Cell Carcinoma.

Rodrigo Pérez Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.